(Q34281909)

1 August 2017

1 reference

title

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. (English)

1 reference

1 August 2017

2

1 reference

1 August 2017

E Abalos

1

1 reference

1 August 2017

D W Steyn

series ordinal

3

1 reference

1 August 2017

D J Henderson-Smart

series ordinal

4

1 reference

1 August 2017

publication date

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

1 August 2017

published in

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

CD002252

1 reference

A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Effect of calcium channel blocker nifedipine on uterine artery flow velocity waveforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

The classification and definition of the hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Effects of nifedipine on resistance vessels, arteries and veins in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Nifedipine administered in pregnancy: effect on the development of children at 18 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

A randomized comparison of early with conservative use of antihypertensive drugs in the management of pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Gruppo di Studio Ipertensione in Gravidanza

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Hypertension during pregnancy with and without specific treatment; the development of the children at the age of four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Use of labetalol and methyldopa in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Blood rheology in pre-eclampsia and intrauterine growth retardation: effects of blood pressure reduction with labetalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

Evaluation of a definition of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

The measuring of blood pressure during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002252

10.1002/14651858.CD002252

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference